Kiora Pharmaceuticals' Corporate Controller resigns; CEO appointed as interim principal financial officer

KIORA PHARMACEUTICALS INC

Michael Meluzio resigned as Corporate Controller and interim principal financial/accounting officer on March 18, 2022.
Brian M. Strem, Ph.D., President and CEO, appointed as principal financial and accounting officer effective March 18, 2022.
Company engaged Danforth Advisors, LLC for interim finance and accounting services until a permanent replacement is found.
Resignation not due to any disagreement with company's operations, policies, or practices.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Brian M. Strem

President and Chief Executive Officer

KPRX · KIORA PHARMACEUTICALS INC

Effective: 2022-03-18
Filed: March 23, 2022, 7:59 PM ET

Effective as of March 18, 2022, Brian M. Strem, Ph.D., the Company’s President and Chief Executive Officer, was appointed as the Company’s principal financial officer and principal accounting officer.

Departed (interim)

Michael Meluzio

Corporate Controller

KPRX · KIORA PHARMACEUTICALS INC

Effective: 2022-03-18
Successor: Brian M. Strem
Filed: March 23, 2022, 7:59 PM ET

On March 18, 2022, Michael Meluzio resigned as the Corporate Controller of Kiora Pharmaceuticals, Inc. (the “Company”) to pursue other opportunities.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Brian M. Strem was appointed as President and Chief Executive Officer at KIORA PHARMACEUTICALS INC.

Action: appointed
Role: President and Chief Executive Officer

Exact text from the filing

Effective as of March 18, 2022, Brian M. Strem, Ph.D., the Company’s President and Chief Executive Officer, was appointed as the Company’s principal financial officer and principal accounting officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Meluzio resigned as Corporate Controller at KIORA PHARMACEUTICALS INC.

Action: resigned
Role: Corporate Controller

Exact text from the filing

On March 18, 2022, Michael Meluzio resigned as the Corporate Controller of Kiora Pharmaceuticals, Inc. (the “Company”) to pursue other opportunities.

View on SEC.gov

KIORA PHARMACEUTICALS INC filing history →

Source: SEC EDGAR

accession 0001104659-22-037086

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.